FDA Inspection 1229061 — Catalent Pharma Solutions LLC

Catalent Pharma Solutions LLC — FEI 1000110912

The FDA completed an inspection of Catalent Pharma Solutions LLC on May 24, 2024 in Morrisville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Morrisville, NC (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance